These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31871503)

  • 1. Efficacy of Periodic Intensive Insulin Therapy on secondary complications of diabetes warrants larger prospective randomized clinical trials.
    Lakey J
    Curr Ther Res Clin Exp; 2019; 91():23. PubMed ID: 31871503
    [No Abstract]   [Full Text] [Related]  

  • 2. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
    Duron F
    Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results.
    Colwell JA
    Diabetes; 1996 Jul; 45 Suppl 3():S87-90. PubMed ID: 8674902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive ambulatory treatment of insulin-dependent diabetes.
    Felig P; Bergman M
    Ann Intern Med; 1982 Aug; 97(2):225-30. PubMed ID: 7049031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.
    Umpierrez G; Cardona S; Pasquel F; Jacobs S; Peng L; Unigwe M; Newton CA; Smiley-Byrd D; Vellanki P; Halkos M; Puskas JD; Guyton RA; Thourani VH
    Diabetes Care; 2015 Sep; 38(9):1665-72. PubMed ID: 26180108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.
    Linn T; Ortac K; Laube H; Federlin K
    Metabolism; 1996 Dec; 45(12):1508-13. PubMed ID: 8969284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.